Cullen/Frost Bankers’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93K Buy
172
+33
+24% +$1.05K ﹤0.01% 1222
2026
Q1
$4.38K Buy
+139
New +$4.38K ﹤0.01% 1190
2023
Q2
– Sell
-326
Closed -$11.9K – 1253
2023
Q1
$11.9K Buy
326
+29
+10% +$915 ﹤0.01% 923
2022
Q4
$9.15K Buy
+297
New +$9.22K ﹤0.01% 931

Other funds holding RTO

Cullen/Frost Bankers's RTO Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Rentokil (RTO) stake by 24% in Q2 2026, buying an estimated $1.05K and bringing the position to 172 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Cullen/Frost Bankers first reported a position in RTO in Q4 2022 and has held it in 4 quarters since. The position peaked at $11.9K in Q1 2023. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Cullen/Frost Bankers held 172 shares of Rentokil worth $4.93K as of Q2 2026.
  • Cullen/Frost Bankers bought 33 Rentokil shares in Q2 2026, an estimated $1.05K.
  • Rentokil made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1222 holding.
  • Cullen/Frost Bankers first reported a position in Rentokil in Q4 2022 and has held it in 4 quarters since.
  • Cullen/Frost Bankers's Rentokil position peaked at $11.9K in Q1 2023.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.